Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 4/20 | 0.67 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.67 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.67 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.67 |
| ▸ | CHRNA2 | Q15822 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.67 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.67 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.67 |
| ▸ | HTR3B | O95264 | 1/20 | 0.67 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.67 |
| ▸ | CHRNG | P07510 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.67 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1538388 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL11062243 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL15043452 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL1538387 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL1538474 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL10886848 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL11060251 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL9298664 | 0.85 | CHRNB2 (0.55) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL10891035 | 0.85 | CHRNB2 (0.55) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 | |
| SCHEMBL9298532 | 0.85 | CHRNB2 (0.55) | CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2050749-B1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-8022205-B2 | Pyrimidine derivatives as PI3K inhibitor and use thereof | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20100069629-A1 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-03-18 | — | — | US | disclosed |
| EP-2050749-A1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069629-A1 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF | PIK3CA, AKT3, AKT1 | CHRNB2 4856/4885CHRNA4 4839/4885CHRNA7 4804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.